出血性卡波西肉瘤。α干扰素治疗成功。
Hemorrhagic Kaposi sarcoma. Successful treatment with IFN-alpha.
作者信息
Bassioukas Konstantinos, Zioga Aikateneri, Hantschke Markus, Klouvas George, Hatzis John
机构信息
Department of Skin and Venereal Diseases, Medical School, University of Ioannina, 45110 Ioannina, Greece.
出版信息
Eur J Dermatol. 2004 Jan-Feb;14(1):37-40.
PMID:14965794
Abstract
A 76-year-old woman with atypical hemorrhagic Kaposi sarcoma is presented. The patient was treated with recombinant interferon alpha-2b (3,000,000 IU) subcutaneously, three times weekly for 6 months and twice weekly as maintenance dose for 14 months with excellent response and no recurrence after a 7 years of follow-up.
摘要
报告了一名患有非典型出血性卡波西肉瘤的76岁女性。该患者接受了重组干扰素α-2b（300万国际单位）皮下注射治疗，每周三次，共6个月，之后作为维持剂量每周两次，持续14个月，反应良好，随访7年无复发。
相似文献
1
Hemorrhagic Kaposi sarcoma. Successful treatment with IFN-alpha.出血性卡波西肉瘤。α干扰素治疗成功。
Eur J Dermatol. 2004 Jan-Feb;14(1):37-40.
2
[Intralesional treatment of classical Kaposi sarcoma with interferon-alpha].
Hautarzt. 1992 Dec;43(12):789-91.
3
Classic Kaposi sarcoma treated with intralesional 5-aminolevulinic acid injection photodynamic therapy.采用病灶内注射5-氨基酮戊酸光动力疗法治疗经典型卡波西肉瘤。
Arch Dermatol. 2009 Oct;145(10):1200-2. doi: 10.1001/archdermatol.2009.241.
4
Treatment of advanced classic Kaposi's sarcoma with weekly low-dose paclitaxel therapy.
Int J Dermatol. 2006 Dec;45(12):1441-3. doi: 10.1111/j.1365-4632.2006.03142.x.
5
Classic Kaposi's sarcoma: low-dose interferon alfa treatment.经典型卡波西肉瘤：低剂量干扰素α治疗
Dermatology. 1998;197(1):37-42. doi: 10.1159/000017973.
6
Effective treatment of Kaposi sarcoma with everolimus in a patient with membranous glomerulonephritis.
Intern Med J. 2015 Feb;45(2):230-1. doi: 10.1111/imj.12655.
7
Intralesional interferon alpha-2b therapy for adnexal Kaposi sarcoma.皮损内注射干扰素α-2b治疗附件卡波西肉瘤。
Cornea. 2009 Sep;28(8):941-3. doi: 10.1097/ICO.0b013e3181967338.
8
Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not".肾移植患者卡波西肉瘤的分子靶向治疗：病例报告，“哪些有效，哪些无效”
BMC Nephrol. 2007 Mar 27;8:6. doi: 10.1186/1471-2369-8-6.
9
Clinical and immunologic effects of subcutaneously administered interleukin-12 and interferon alfa-2b: phase I trial of patients with metastatic renal cell carcinoma or malignant melanoma.皮下注射白细胞介素-12和干扰素α-2b的临床及免疫效应：转移性肾细胞癌或恶性黑色素瘤患者的I期试验
J Clin Oncol. 2004 Jul 15;22(14):2891-900. doi: 10.1200/JCO.2004.10.045.
10
Non-AIDS-associated Kaposi's sarcoma (classical and endemic African types): treatment with low doses of recombinant interferon-alpha.非艾滋病相关的卡波西肉瘤（经典型和非洲地方性流行型）：低剂量重组干扰素-α治疗
J Invest Dermatol. 1990 Dec;95(6 Suppl):176S-179S. doi: 10.1016/s0022-202x(90)91216-x.
引用本文的文献
1
Histological variants of cutaneous Kaposi sarcoma.皮肤卡波西肉瘤的组织学变异型。
Diagn Pathol. 2008 Jul 25;3:31. doi: 10.1186/1746-1596-3-31.
Zotero 插件